Abstract
Lenka Hromadkova, Chae Kim, Tracy Haldiman, Mohammad Khursheed Siddiqi, Krystyna Surewicz, Kiley Urquhart, Dur-E-Nayab Sadruddin, Lihua Peng, Xiongwei Zhu, Witold K. Surewicz, Mark L. Cohen, Mark R. Chance, Rohan de Silva, Janna Kiselar, Jiri G. Safar
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Genome-wide association studies identify novel loci in rapidly progressive Alzheimer’s disease
10.1002/alz.13655 · 2024
Molecular mechanisms encoding strains of prions and prion-like misfolded proteins.
10.1007/978-3-031-20565-1_7 · 2023
Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease
2022
Rapidly progressive Alzheimer’s disease features distinct structures of amyloid-β
10.1093/brain/awv006 · 2015
Pre-progression rates in Alzheimer’s disease revisited
10.3233/jad-130074 · 2013
Rapidly progressive Alzheimer disease
10.1001/archneurol.2011.189 · 2011
Rapidly progressive dementias - aetiologies, diagnosis and management
10.1038/s41582-022-00659-0 · 2022
Alzheimer’s disease: genetic polymorphisms and rate of decline
10.1159/000336790 · 2012
Clinical features of rapidly progressive Alzheimer’s disease
10.1159/000278692 · 2010
Rapidly progressive Alzheimer’s disease: a multicenter update
10.3233/jad-2012-120007 · 2012
Rapidly Progressive Alzheimer’s Disease in Two Distinct Autopsy Cohorts
10.3233/jad-180155 · 2018
Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer’s disease
10.1016/j.jbc.2021.101267 · 2021
Phosphorylated tau interactome in the human Alzheimer’s disease brain
10.1093/brain/awaa223 · 2020
Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease
10.1007/s00401-017-1691-0 · 2017
The basis of cellular and regional vulnerability in Alzheimer’s disease
10.1007/s00401-019-02054-4 · 2019
The genetics and neuropathology of Alzheimer’s disease
10.1007/s00401-012-0996-2 · 2012
Alzheimer’s disease
10.1101/cshperspect.a004457 · 2011
The genetic landscape of Alzheimer disease: clinical implications and perspectives
10.1038/gim.2015.117 · 2016
Cryo-EM structures of Tau filaments from Alzheimer’s disease brain
10.1038/nature23002 · 2017
Fibril structure of amyloid-β(1-42) by cryo-electron microscopy
10.1126/science.aao2825 · 2017
Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases
2019
Ordered Assembly of Tau Protein and Neurodegeneration
10.1007/978-981-32-9358-8_1 · 2019
Prion-like strain effects in tauopathies
2022
Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation
10.1007/s00401-020-02148-4 · 2020
Disease-specific tau filaments assemble via polymorphic intermediates
10.1038/s41586-023-06788-w · 2024
All the Tau We Cannot See
10.1146/annurev-med-042921-023749 · 2023
Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
10.1186/s13578-023-01133-0 · 2023
Quantitative protein topography analysis and high-resolution structure prediction using hydroxyl radical labeling and tandem-ion mass spectrometry (MS)
10.1074/mcp.o114.044362 · 2015
A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution
10.1021/bi5010409 · 2014
Structural analysis of proinsulin hexamer assembly by hydroxyl radical footprinting and computational modeling
10.1074/jbc.m111.297853 · 2011
Future directions of structural mass spectrometry using hydroxyl radical footprinting
10.1002/jms.1808 · 2010
Early clinical PET imaging results with the novel PHF-tau radioligandF18-T808
10.3233/jad-130098 · 2014
Highly elevated cerebrospinal fluid total tau level reflects higher likelihood of non-amnestic subtype of Alzheimer’s Disease
2019
O5-04-02: Altered Protein Expression in Amyloid Plaques in Rapidly Progressive Alzheimer’s Disease
10.1016/j.jalz.2016.06.723 · 2016
Structural determinants of phenotypic diversity and replication rate of human prions
10.1371/journal.ppat.1004832 · 2015
Prion infectivity plateaus and conversion to symptomatic disease originate from falling precursor levels and increased levels of oligomeric PrPSc species
10.1128/jvi.02142-15 · 2015
Prion disease tempo determined by host-dependent substrate reduction
10.1172/jci72241 · 2014
Unresolved referenced work
Kept as external metadata until matched
Small protease sensitive oligomers of PrPSc determine replication rate in distinct prion strains
2012
Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate
2011
Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
10.1186/s13195-017-0279-1 · doi-reference
Centering, scaling, and transformations: improving the biological information content of metabolomics data
10.1186/1471-2164-7-142 · doi-reference
Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting
10.4161/mabs.22964 · doi-reference
Hydroxyl radical-mediated modification of proteins as probes for structural proteomics
10.1021/cr0682047 · doi-reference
Secondary reactions and strategies to improve quantitative protein footprinting
10.1021/ac048282z · doi-reference
Phosphomimetic substitutions in TDP-43’s transiently α-helical region suppress phase separation
10.1016/j.bpj.2024.01.001 · doi-reference
Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity
10.1002/pro.5560021220 · doi-reference
Human prions and plasma lipoproteins
10.1073/pnas.0604021103 · doi-reference
Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain
10.1126/scitranslmed.aat8462 · doi-reference
Selective precipitation of prions by polyoxometalate complexes
10.1021/ja055219y · doi-reference
Variations in filament conformation dictate seeding barrier between three- and four-repeat tau
10.1021/bi2004685 · doi-reference
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
10.1073/pnas.0908005106 · doi-reference
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies
10.1046/j.1365-2990.2003.00463.x · doi-reference
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
10.1093/brain/awr179 · doi-reference
DNA sequencing with chain-terminating inhibitors
10.1073/pnas.74.12.5463 · doi-reference
Diagnosis of human prion disease
10.1073/pnas.0409651102 · doi-reference
Genetic influence on the structural variations of the abnormal prion protein
10.1073/pnas.97.18.10168 · doi-reference
The National Alzheimer’s Coordinating Center (NACC) database: the Uniform Data Set
10.1097/wad.0b013e318142774e · doi-reference
National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease
10.1016/j.jalz.2011.10.007 · doi-reference
National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
10.1007/s00401-011-0910-3 · doi-reference
The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
10.1016/j.jalz.2011.03.005 · doi-reference
Modeling the heterogeneity in risk of progression to Alzheimer’s disease across cognitive profiles in mild cognitive impairment
10.1186/alzrt168 · doi-reference
Sporadic human prion diseases: molecular insights and diagnosis
10.1016/s1474-4422(12)70063-7 · doi-reference
2.7 Å cryo-EM structure of ex vivo RML prion fibrils
10.1038/s41467-022-30457-7 · doi-reference
Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s Disease
10.1016/j.cell.2020.10.029 · doi-reference
Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage-gated calcium channels and NADPH oxidase
10.1111/febs.15340 · doi-reference
Hyperphosphorylated Tau Inflicts Intracellular Stress Responses that Are Mitigated by Apomorphine
10.1007/s12035-023-03689-x · doi-reference
Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca2+ handling
10.1016/j.bbadis.2018.07.011 · doi-reference
Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death
10.1016/j.ceca.2019.102150 · doi-reference
Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells
10.1016/j.mcn.2007.12.010 · doi-reference
Characteristics and consequences of muscarinic receptor activation by tau protein
10.1016/j.euroneuro.2009.04.006 · doi-reference
Extracellular tau is toxic to neuronal cells
10.1016/j.febslet.2006.07.078 · doi-reference
Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold
10.1007/s00401-018-1914-z · doi-reference
Tau filaments in neurodegenerative diseases
10.1002/1873-3468.13108 · doi-reference
Mechanisms of tau and Aβ-induced excitotoxicity
10.1016/j.brainres.2015.12.048 · doi-reference
Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability
10.1016/j.jalz.2017.04.002 · doi-reference
A cell culture model for investigation of synapse influenceability: epigenetics, expression and function of gene targets important for synapse formation and preservation in SH-SY5Y neuroblastoma cells differentiated by retinoic acid
10.1007/s00702-017-1769-9 · doi-reference
β-Sheet core of tau paired helical filaments revealed by solid-state NMR
10.1021/ja305470p · doi-reference
Diagnostic and prognostic value of human prion detection in cerebrospinal fluid
10.1002/ana.24833 · doi-reference
Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
10.1186/s40478-018-0508-2 · doi-reference